
Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2
Keywords: Cancer; Epidermal growth factor receptor (EGFR); Human epidermal growth factor receptor 2 (HER2); Lapatinib; (â)-epigallocatechin-3-O-gallate (EGCG); Molecular dynamics simulations;